Higher-risk Myelodysplastic Syndrome
📧 Sign up to get email alerts when something new happens for Higher-risk Myelodysplastic Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: First-in-human (FIH) Trial of GEN3018 in Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-risk Myelodysplastic Syndrome (HR-MDS) [Phase 1]
Genmab announced a first-in-human Phase 1 trial of GEN3018 in relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic syn…